Bruker Chemical and Applied Markets offers three LC-triple quadrupole (LC-TQ) mass spectrometers, the EVOQ Qube, the EVOQ Elite, and the EVOQ Elite ER.
Bruker Chemical and Applied Markets (CAM) offers three LC-triple quadrupole (LC-TQ) mass spectrometers, the EVOQ Qube, the EVOQ Elite, and the EVOQ Elite ER.
All systems incorporate Bruker’s Advance Ultra-High Pressure Liquid Chromatography (UHPLC) systems. The Advance HPLC, UHPLC, and the UHPLC-OLE products offer ultra-low dead-volume, which enables excellent reproducibility at analytical flow-rates, an integrated column-oven, and bench-space savings, the company reports. Paired with the CTC auto-sampler, the Advance LC portfolio delivers precision and accuracy required for sustained, high-sensitivity LC-MRM quantitative analysis.
Innovations include the first Vacuum-Insulated Probe (VIP) heated electrospray technology, which preserves and ionizes thermally fragile molecules; an Active Exhaust atmospheric pressure ionization source with a robust orifice vacuum interface, which enhances quantitative robustness for difficult samples; a proprietary Interlaced Quadrupole Dual Funnel (IQ-DF), which maximizes sensitivity; and, PACER software, which enables ‘exception based data-review’, a revolutionary feature that significantly reduces the error rate for quantitative analysis.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.